VLDLR and hyperinsulinism: Thereby, insulin resistance as well as hyperinsulinemia are thought to influence hepatic free cholesterol content by activating low density lipoprotein receptor (LDLR) via SREBP-2 as well as hepatic cholesterol uptake.